2nd ALS Drug Development Summit
May
16

2nd ALS Drug Development Summit

 May 16 to May 18, 2023 

Hilton Boston Logan Airport, One Hotel Drive, Boston, Massachusetts, 02128, United States


Following the approval of Amylyx's Relyvrio in the US and Canada and further FDA decisions on the horizon in 2023, the ALS drug development landscape is gaining momentum and positivity. With booming pharma investment and new biotechs entering the field, there are still crucial translational challenges to address to bridge the gap and see clinical success for the wider ALS patient population.

Returning to Boston, the timely 2nd Annual ALS Drug Development Summit is the only industry-focused conference dedicated to overcoming preclinical and clinical challenges currently facing ALS pipelines. This is your must-attend meeting showcasing the latest breakthroughs in ALS in 2022 and 2023.

Read on go.evvnt.com

Continue reading at

Related Offerings

Interested in this event?


Next Event

  • May
    17

    LUPUS And KCR 2023

     May 17 to May 20, 2023 

    COEX, 513 Yeongdong-daero, Gangnam-gu, Seoul, 06164, Korea (South)

    LUPUS And KCR 2023

Medigy Innovation Network

Connecting innovation decision makers to authoritative information, institutions, people and insights.

Medigy Logo

The latest News, Insights & Events

Medigy accurately delivers healthcare and technology information, news and insight from around the world.

The best products, services & solutions

Medigy surfaces the world's best crowdsourced health tech offerings with social interactions and peer reviews.


© 2024 Netspective Media LLC. All Rights Reserved.

Built on Mar 5, 2024 at 4:28am